Chaudhry M S Sarwar1, Muthiah Vaduganathan2, Javed Butler3. 1. Cardiology Division, Health Sciences Center, Stony Brook University, T-16, Room 080 SUNY, Stony Brook, NY, 11794, USA. 2. Brigham and Women's Hospital Heart and Vascular Center, Boston, MA, USA. 3. Cardiology Division, Health Sciences Center, Stony Brook University, T-16, Room 080 SUNY, Stony Brook, NY, 11794, USA. javed.butler@stonybrookmedicine.edu.
Abstract
PURPOSE OF REVIEW: There are over 25 million patients living with heart failure globally. Overall, and especially post-discharge, clinical outcomes have remained poor in heart failure despite multiple trials, with both successes and failures over the last two decades. Matching therapies to the right patient population, identifying high-quality sites, and ensuring optimal trial design and execution represent important considerations in the development of novel therapeutics in this space. RECENT FINDINGS: While clinical trials have undergone rapid globalization, this has come with regional variation in comorbidities, clinical parameters, and even clinical outcomes and treatment effects across international sites. These issues have now highlighted knowledge gaps about the conduct of trials, selection of study sites, and an unmet need to develop and identify "ideal" sites. There is a need for all stakeholders, including academia, investigators, healthcare organizations, patient advocacy groups, industry sponsors, research organizations, and regulatory authorities, to work as a multidisciplinary group to address these problems and develop practical solutions to improve trial conduct, efficiency, and execution. We review these trial-level issues using examples from contemporary studies to inform and optimize the design of future global clinical trials in heart failure.
PURPOSE OF REVIEW: There are over 25 million patients living with heart failure globally. Overall, and especially post-discharge, clinical outcomes have remained poor in heart failure despite multiple trials, with both successes and failures over the last two decades. Matching therapies to the right patient population, identifying high-quality sites, and ensuring optimal trial design and execution represent important considerations in the development of novel therapeutics in this space. RECENT FINDINGS: While clinical trials have undergone rapid globalization, this has come with regional variation in comorbidities, clinical parameters, and even clinical outcomes and treatment effects across international sites. These issues have now highlighted knowledge gaps about the conduct of trials, selection of study sites, and an unmet need to develop and identify "ideal" sites. There is a need for all stakeholders, including academia, investigators, healthcare organizations, patient advocacy groups, industry sponsors, research organizations, and regulatory authorities, to work as a multidisciplinary group to address these problems and develop practical solutions to improve trial conduct, efficiency, and execution. We review these trial-level issues using examples from contemporary studies to inform and optimize the design of future global clinical trials in heart failure.
Entities:
Keywords:
Clinical trials; Geographic variation; Heart failure; Outcomes; Site selection; Study design
Authors: Jessica L Mega; Eugene Braunwald; Stephen D Wiviott; Jean-Pierre Bassand; Deepak L Bhatt; Christoph Bode; Paul Burton; Marc Cohen; Nancy Cook-Bruns; Keith A A Fox; Shinya Goto; Sabina A Murphy; Alexei N Plotnikov; David Schneider; Xiang Sun; Freek W A Verheugt; C Michael Gibson Journal: N Engl J Med Date: 2011-11-13 Impact factor: 91.245
Authors: Seth W Glickman; John G McHutchison; Eric D Peterson; Charles B Cairns; Robert A Harrington; Robert M Califf; Kevin A Schulman Journal: N Engl J Med Date: 2009-02-19 Impact factor: 91.245
Authors: Matthew E Harinstein; Javed Butler; Stephen J Greene; Gregg C Fonarow; Norman L Stockbridge; Christopher M O'Connor; Marc A Pfeffer; Mandeep R Mehra; Scott D Solomon; Clyde W Yancy; Mona Fiuzat; Robert J Mentz; Sean P Collins; John J V McMurray; Muthiah Vaduganathan; Preston M Dunnmon; Giuseppe M C Rosano; Wilfried Dinh; Frank Misselwitz; Robert O Bonow; Mihai Gheorghiade Journal: Heart Fail Rev Date: 2015-07 Impact factor: 4.214
Authors: Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-02-23 Impact factor: 29.690
Authors: Marc A Pfeffer; Brian Claggett; Susan F Assmann; Robin Boineau; Inder S Anand; Nadine Clausell; Akshay S Desai; Rafael Diaz; Jerome L Fleg; Ivan Gordeev; John F Heitner; Eldrin F Lewis; Eileen O'Meara; Jean-Lucien Rouleau; Jeffrey L Probstfield; Tamaz Shaburishvili; Sanjiv J Shah; Scott D Solomon; Nancy K Sweitzer; Sonja M McKinlay; Bertram Pitt Journal: Circulation Date: 2014-11-18 Impact factor: 29.690
Authors: John R Teerlink; Gad Cotter; Beth A Davison; G Michael Felker; Gerasimos Filippatos; Barry H Greenberg; Piotr Ponikowski; Elaine Unemori; Adriaan A Voors; Kirkwood F Adams; Maria I Dorobantu; Liliana R Grinfeld; Guillaume Jondeau; Alon Marmor; Josep Masip; Peter S Pang; Karl Werdan; Sam L Teichman; Angelo Trapani; Christopher A Bush; Rajnish Saini; Christoph Schumacher; Thomas M Severin; Marco Metra Journal: Lancet Date: 2012-11-07 Impact factor: 79.321
Authors: Fabrizio Oliva; Andrea Mortara; Giuseppe Cacciatore; Alessandra Chinaglia; Andrea Di Lenarda; Marco Gorini; Marco Metra; Michele Senni; Aldo P Maggioni; Luigi Tavazzi Journal: Eur J Heart Fail Date: 2012-07-25 Impact factor: 15.534
Authors: Mihai Gheorghiade; Kirkwood F Adams; John G F Cleland; Gad Cotter; G Michael Felker; Gerasimos S Filippatos; Gregg C Fonarow; Barry H Greenberg; Adrian F Hernandez; Sadiya Khan; Michel Komajda; Marvin A Konstam; Peter P Liu; Aldo P Maggioni; Barry M Massie; John J McMurray; Mandeep Mehra; Marco Metra; John O'Connell; Christopher M O'Connor; Peter S Pang; Ileana L Piña; Hani N Sabbah; John R Teerlink; James E Udelson; Clyde W Yancy; Faiez Zannad; Norman Stockbridge Journal: Am Heart J Date: 2009-06 Impact factor: 4.749
Authors: Luisa Marilia Cantisano; Rocio Gonzalez-Soltero; Ascensión Blanco-Fernández; Noelia Belando-Pedreño Journal: Int J Environ Res Public Health Date: 2022-07-28 Impact factor: 4.614